MedCity News October 21, 2024
Eve McDavid

Closing cancer health equity gaps requires medical breakthroughs made possible by new funding approaches.

Investors pour billions of dollars into cancer research and treatment innovation each year. However, pennies on the dollar are directed toward rare cancers and cancers such as cervical cancer that disproportionately affect marginalized communities.

In order for these fields to have sufficiently funded research that yields breakthrough advances, the healthcare industry needs novel funding models to target these fields. This is where the greatest innovation potential exists to close cancer equity gaps.

My interest in this field is personal – In 2020, I survived a deadly stage IIB cervical cancer diagnosis. As a healthcare innovator, I’ve seen the critical need for cervical cancer advancements because...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Provider, Trends
‘Switchable’ CAR-T startup raises $112 million
Seaport docks $225m for its improved neuropsychiatry drugs
HLTH: OneStep Secures $36M to Establish Gait Analysis as the Sixth Vital Sign
HLTH: Tennr Raises $37M to Automate Healthcare Documentation, Streamline Patient Referrals
U.S. proposals to curb AI, semiconductor investment into China under final review

Share This Article